PAM
EW icon

Pegasus Asset Management’s Edwards Lifesciences EW Stock Holding History

Pegasus Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-42,628
Closed -$3.16M – 65
2024
Q4 		$3.16M Buy
42,628
+159
+0.4% +$11.1K 1.19% 30
2024
Q3 		$2.8M Sell
42,469
-818
-2% -$59.4K 1.07% 30
2024
Q2 		$4M Buy
43,287
+579
+1% +$51.3K 1.53% 25
2024
Q1 		$4.08M Sell
42,708
-69
-0.2% -$5.8K 1.58% 26
2023
Q4 		$3.26M Buy
42,777
+1,049
+3% +$73K 1.4% 29
2023
Q3 		$2.89M Buy
41,728
+196
+0.5% +$15.8K 1.34% 30
2023
Q2 		$3.92M Sell
41,532
-251
-0.6% -$21.8K 1.74% 24
2023
Q1 		$3.46M Sell
41,783
-61
-0.1% -$4.79K 1.71% 24
2022
Q4 		$3.12M Buy
41,844
+289
+0.7% +$22.3K 1.69% 26
2022
Q3 		$3.43M Sell
41,555
-552
-1% -$53.1K 1.94% 18
2022
Q2 		$4M Sell
42,107
-1,234
-3% -$128K 2.18% 14
2022
Q1 		$5.1M Sell
43,341
-354
-0.8% -$39.7K 2.21% 10
2021
Q4 		$5.66M Buy
43,695
+243
+0.6% +$28.3K 2.32% 10
2021
Q3 		$4.92M Sell
43,452
-25
-0.1% -$2.85K 2.26% 10
2021
Q2 		$4.5M Sell
43,477
-209
-0.5% -$19.7K 2.1% 13
2021
Q1 		$3.65M Buy
43,686
+1,419
+3% +$120K 1.85% 17
2020
Q4 		$3.86M Buy
42,267
+45
+0.1% +$3.73K 2.11% 13
2020
Q3 		$3.37M Buy
42,222
+101
+0.2% +$7.88K 2.11% 14
2020
Q2 		$2.91M Sell
42,121
-230
-0.5% -$16.3K 1.99% 14
2020
Q1 		$2.66M Buy
42,351
+456
+1% +$32.9K 2.2% 14
2019
Q4 		$3.26M Sell
41,895
-567
-1% -$44.3K 2.14% 14
2019
Q3 		$3.11M Buy
42,462
+129
+0.3% +$9.06K 2.26% 12
2019
Q2 		$2.61M Sell
42,333
-15
-0% -$907 2.02% 20
2019
Q1 		$2.7M Sell
42,348
-660
-2% -$37.7K 2.22% 14
2018
Q4 		$2.2M Sell
43,008
-210
-0.5% -$10.6K 2.07% 19
2018
Q3 		$2.51M Buy
43,218
+2,856
+7% +$140K 2.1% 14
2018
Q2 		$1.96M Buy
40,362
+2,115
+6% +$98.7K 1.83% 26
2018
Q1 		$1.78M Sell
38,247
-630
-2% -$27.4K 1.69% 27
2017
Q4 		$1.46M Buy
+38,877
New +$1.43M 1.46% 30

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Pegasus Asset Management's EW Position: Q1 2025 in Review

Pegasus Asset Management sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 42,628 shares — an estimated $3.16M sold.

Pegasus Asset Management first reported a position in EW in Q4 2017 and held it in 29 quarters. The position peaked at $5.66M in Q4 2021. 1,205 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • Pegasus Asset Management reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • Pegasus Asset Management sold 42,628 Edwards Lifesciences shares in Q1 2025, an estimated $3.16M.
  • Pegasus Asset Management first reported a position in Edwards Lifesciences in Q4 2017 and held it in 29 quarters.
  • Pegasus Asset Management's Edwards Lifesciences position peaked at $5.66M in Q4 2021.
  • 1,205 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Pegasus Asset Management's 13F filing for Q1 2025, filed 21 Apr 2025.